TELESTA THERAPEUTICS INC T.TST

bristol capital webinar/call july 14

[cashmeout]

We will be hosting a group webinar/call with Telesta management on Tuesday, July 14th at 11AM ET. The webcast will focus on this filing and what it means to TST and provide a broader overview of the business with a power point review including an open Q and A session with management. Please let me know if you would like to register and listen to this presentation?

MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy. The preparation of this submission has been their corporate focus for the first 6 months of the year and they put all of their efforts into not just meeting this internal target submission date, but also into ensuring that their MCNA BLA we is the strongest BLA they could produce, in support of what could be the first new approved drug for non-muscle invasive bladder cancer in the United States in almost 20 years.
Based on their interaction with the FDA, potential partners, the urology community and the investment community, they are feeling very positive about both the potential for approval in the US as well as the commercial prospects for MCNA. On the commercial side, MCNA has an almost perfect profile as a specialty pharma product, with attributes including:

- Near-term potential for approval/revenue (Q1/2016 if the FDA grants priority approval)
- Large market opportunity with premium oncology pricing (3rd Party Market Analysis: >$400 million peak sales in the US)
- Small speciality sales force
- No competition
- Strong IP coverage (to 2031)

Again, please let me know if you would like to participate and listen to our July 14th at 11AM ET webcast?


Thanks

Glen Akselrod
Bristol Capital Ltd.
250 Rodinea Rd, 2nd Floor
Vaughan, Ontario, L6A 4P5
Telephone: [phone] ext 10
Fax: [phone]
E-Mail: [e-mail]
Website: www.bristolir.com

[rgonlyfactspls]

Cashmeout...THANK YOU for sharing! Very good to know (listen/watch on 14th). And, thought the concise overview of TST/MCNA & BLA submission is excellent. P.S...Blockbuster: Maybe you could share this with the "non-converted" (i.e., post this Bristol/TST upcoming webinar/call announcement on other pharma / biotech bullboards you frequent)?? - I (for one) would not be offended if you

[HighteawithIntrepid]

Thanks for info  you may want to suggest that the call be added to Telesta web page

[13PunterDog]

Yes Cash, Thanx for the post, very informative. Also props to management, another step checked off your list. They just do what they say they are going to do. Very refreshing. Hopefully 8 months from now we are selling MCNA to patients. Cheers GLTA Longs 13PD